Ginkgo Bioworks Holdings Aktie
WKN DE: A3C3B4 / ISIN: US37611X1000
15.08.2024 11:27:00
|
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?
To say the past year has been rough for investors in Ginkgo Bioworks (NYSE: DNA) would be an understatement of the highest order. As of Aug 14, shares of the synthetic-biology stock were down by 86% in 2024.A beaten-down price isn't the only way the stock market has signaled low expectations. Ginkgo stock has been trading at a steeply negative enterprise value.It's a debt-free company that finished June with $730 million in cash and cash equivalents. The stock has been beaten down so severely, though, that you could buy every outstanding share for just $524 million at recent prices.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ginkgo Bioworks Holdingsmehr Nachrichten
Keine Nachrichten verfügbar. |